BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 11100356)

  • 1. Multimodal therapy of hepatocarcinoma: personal experience on 90 cases.
    Puleo S; Lombardo R; Li Destri G; Azzarello G; Rinzivillo C; Di Carlo I
    Hepatogastroenterology; 2000; 47(35):1379-81. PubMed ID: 11100356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatocarcinoma: considerations on surgical treatment in a personal series of 23 patients.
    Taschieri AM; Elli M; Cristaldi M; Rovati MP; Danelli PG; Vignati A; Sampietro GM; Taschieri S
    Hepatogastroenterology; 1999; 46(28):2500-3. PubMed ID: 10522027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hepatocellular carcinoma: percutaneous ethanol injection/transarterial chemoembolization/radiofrequency thermoablation].
    Allgaier HP; Rossi S; Deibert P; Zuber I; Hering M; Blum HE
    Praxis (Bern 1994); 2000 Jun; 89(24):1056-60. PubMed ID: 10902462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination therapy with transcatheter arterial embolization and percutaneous ethanol injection for advanced hepatocellular carcinoma.
    Koda M; Okamoto K; Miyoshi Y; Kato S; Murawaki Y; Horie Y; Suou T; Kawasaki H
    Hepatogastroenterology; 1994 Feb; 41(1):25-9. PubMed ID: 8175109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of reduction surgery in multidisciplinary treatment of advanced hepatocellular carcinoma with multiple intrahepatic lesions.
    Wakabayashi H; Ushiyama T; Ishimura K; Izuishi K; Karasawa Y; Masaki T; Watanabe S; Kuriyama S; Maeta H
    J Surg Oncol; 2003 Feb; 82(2):98-103. PubMed ID: 12561065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcatheter arterial chemoembolization therapy combined with percutaneous ethanol injection for unresectable large hepatocellular carcinoma: an evaluation of the local therapeutic effect and survival rate.
    Dohmen K; Shirahama M; Shigematsu H; Miyamoto Y; Torii Y; Irie K; Ishibashi H
    Hepatogastroenterology; 2001; 48(41):1409-15. PubMed ID: 11677976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Long-term results of interventional treatment of large unresectable hepatocellular carcinoma (HCC): significant survival benefit from combined transcatheter arterial chemoembolization (TACE) and percutaneous ethanol injection (PEI) compared to TACE monotherapy].
    Lubienski A; Bitsch RG; Schemmer P; Grenacher L; Düx M; Kauffmann GW
    Rofo; 2004 Dec; 176(12):1794-802. PubMed ID: 15573291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of spontaneous bleeding due to hepatocellular carcinoma.
    Recordare A; Bonariol L; Caratozzolo E; Callegari F; Bruno G; Di Paola F; Bassi N
    Minerva Chir; 2002 Jun; 57(3):347-56. PubMed ID: 12029230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of primary hepatocarcinoma with chemoembolization and alcohol injection. Personal experience].
    Florio F; Nardella M; Balzano S; Andriulli A; Caturelli E; Siena D; Bisceglia M; Fusilli S; Scarale MG; Cammisa M
    Radiol Med; 1994 Dec; 88(6):821-6. PubMed ID: 7878242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnostic imaging and interventional therapy in hepatocarcinoma. Multicenter study of 290 cases].
    Dalla Palma L; Pozzi Mucelli R; Sponza M; Bartolozzi C; Lencioni R; Florio F; De Santis M; Gandini G; Matricardi L; Rossi C; Simonetti G; Pocek M
    Radiol Med; 1997; 94(1-2):30-6. PubMed ID: 9424647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Partial resection of primary liver cell cancer].
    Kremer B; Henne-Bruns D; Jordan A; Witte G
    Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir; 1990; ():153-6. PubMed ID: 1983546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Advanced hepatocellular carcinoma: therapeutic results in 110 patients and therapeutic strategy].
    Inoue Y; Ishida T; Murakami T; Nakamura H
    Gan To Kagaku Ryoho; 1998 Oct; 25(12):1857-64. PubMed ID: 9797808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multimodal treatment of stage IVa hepatocellular carcinoma.
    Harada T; Matsuo K; Inoue T; Inoue T; Tamesue S; Inoue T
    Hepatogastroenterology; 1996; 43(11):1154-8. PubMed ID: 8908544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Multimodal treatment of hepatocellular carcinoma].
    De Santibañes E; Mc Cormack L; Pekolj J; Mattera J; Acuña Barrios J; Aldet A; García Monaco R; Gadano A; D'Agostino D; Bonofiglio C; Ciardullo M
    Acta Gastroenterol Latinoam; 2001; 31(5):367-75. PubMed ID: 11873663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Influence of different treatment modalities on survival of patients with two -stage resection of unresectable hepatocellular carcinoma].
    Fan J; Wu Z; Tang Z
    Zhonghua Wai Ke Za Zhi; 2001 Oct; 39(10):745-8. PubMed ID: 16201184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of large hepatocellular carcinoma: comparison between techniques and long term results.
    Ferrari FS; Stella A; Gambacorta D; Magnolfi F; Fantozzi F; Pasquinucci P; Civeli L; Pieraccini M
    Radiol Med; 2004 Oct; 108(4):356-71. PubMed ID: 15525889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocellular carcinoma: multimodality management.
    Christians KK; Pitt HA; Rilling WS; Franco J; Quiroz FA; Adams MB; Wallace JR; Quebbeman EJ
    Surgery; 2001 Oct; 130(4):554-9; discussion 559-60. PubMed ID: 11602884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The present status of treatments for hepatocellular carcinoma.
    Tanikawa K
    Princess Takamatsu Symp; 1995; 25():245-52. PubMed ID: 8875630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Current treatment of hepatocellular carcinoma. Analysis of a series of 123 cases over a 5-year period].
    Popescu I; Ionescu M; Ciurea S; Braşoveanu V; Sârbu-Boeţi P; Hrehoreţ D; Tomulescu V; Alexandrescu S; Dorobanţu B; Grigorie R; Jemna C; Gheorghe L; Anghel R; Croitoru A; Herlea V; Boroş M
    Chirurgia (Bucur); 2005; 100(4):321-31. PubMed ID: 16238194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multimodal approach and its impact on survival for patients with hepatocellular carcinoma.
    Bassanello M; Cillo U; Vitale A; Lumachi F; Ciarleglio FA; Boccagni P; Brolese A; Zanus G; D'Amico F; Senzolo M; D'Amico DF
    Anticancer Res; 2003; 23(5A):4047-53. PubMed ID: 14666717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.